FP7 takes off

The EU's largest ever funding programme for research and technological development, the Seventh Framework Programme (FP7), was launched on 1 January.

The programme cleared its final hurdle when it was adopted by the Council on 18 December 2006. The decision was widely expected following an agreement on a common position between the Parliament and Council in November. The common position meant that the decision could be adopted by the Environment Council without discussion.

With a total budget of €50.521 billion, FP7 will run for of seven years. An additional €2.7 billion has been earmarked for the Euratom programme on nuclear research, which will run for five years. EU Science and Research Commissioner Janez Potocnik hailed the FP7's approval as 'great day' for European Science. 'In financial terms, this is a major improvement over the last framework programme. In real terms, there are 40 per cent more funds on average per year,' he said.

FP7 will aim to build on the accomplishments of the previous research framework programme, and will be implemented through four specific programmes. The 'Cooperation' programme will support research cooperation in a number of key thematic areas. 'Ideas' will fund investigator-driven research through a newly created European Research Council (ERC). The 'People' programme will support training and researchers' career development, while 'Capacities' will fund the coordination and development of research infrastructure, regional research clusters, international cooperation and closer ties between science and society.

Featuring simpler instruments and streamlined procedures for funding and participation, FP7 should facilitate the greater participation by and cooperation between universities, research centres, small and medium sized enterprises (SMEs) and companies on a broad range of research areas. In doing so, the new programme should make headway on the goal of creating a European Research Area (ERA) - the equivalent of a 'common market' for research - to become the world's leading research area.

Under FP7, the highest portion of the budget will go to information and communication technologies (€9.11 billion), followed by health (€6.05 billion), transport (€4.18 billion) and nanotechnology (€3.5 billion), energy (€2.3 billion), and food, agriculture and biotechnology (€1.935 billion). Other budget lines include environmental research (€1.8 billion), space (€1.43 billion), security (€1.35 billion), and social-economic sciences and humanities (€610 million).

Political discussions on FP7 were first held back by the lack of agreement on the EU's financial perspectives for 2007 to 2013. Consensus among the EU's Heads of State and Government on the overall budget was needed before the FP7 budget could be set.

Subsequent negotiations addressed ethical questions related to EU funding for human embryonic stem cell research, the structure of the ERC and the risk-sharing finance facility.

For further information, please visit:
http://cordis.europa.eu/fp7

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...